342 related articles for article (PubMed ID: 29077521)
1. New approaches for identifying and testing potential new anti-asthma agents.
Licari A; Castagnoli R; Brambilla I; Marseglia A; Tosca MA; Marseglia GL; Ciprandi G
Expert Opin Drug Discov; 2018 Jan; 13(1):51-63. PubMed ID: 29077521
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.
Ciprandi G; Tosca MA; Silvestri M; Ricciardolo FLM
Expert Rev Clin Immunol; 2017 Jul; 13(7):715-721. PubMed ID: 28347164
[TBL] [Abstract][Full Text] [Related]
3. From phenotypes to endotypes to asthma treatment.
Agache IO
Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
[TBL] [Abstract][Full Text] [Related]
4. Inundation of asthma target research: Untangling asthma riddles.
Singh J; Shah R; Singh D
Pulm Pharmacol Ther; 2016 Dec; 41():60-85. PubMed ID: 27667568
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of targeting interleukin 5 in asthma.
Walsh GM
BioDrugs; 2013 Dec; 27(6):559-63. PubMed ID: 23728885
[TBL] [Abstract][Full Text] [Related]
6. Emerging airway smooth muscle targets to treat asthma.
Siddiqui S; Redhu NS; Ojo OO; Liu B; Irechukwu N; Billington C; Janssen L; Moir LM
Pulm Pharmacol Ther; 2013 Feb; 26(1):132-44. PubMed ID: 22981423
[TBL] [Abstract][Full Text] [Related]
7. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.
Girodet PO; Ozier A; Bara I; Tunon de Lara JM; Marthan R; Berger P
Pharmacol Ther; 2011 Jun; 130(3):325-37. PubMed ID: 21334378
[TBL] [Abstract][Full Text] [Related]
8. What goes up must come down: biomarkers and novel biologicals in severe asthma.
Hilvering B; Pavord ID
Clin Exp Allergy; 2015 Jul; 45(7):1162-9. PubMed ID: 25640208
[TBL] [Abstract][Full Text] [Related]
9. Emerging interleukin receptor antagonists for the treatment of asthma.
Al Efraij K; FitzGerald JM
Expert Opin Emerg Drugs; 2017 Sep; 22(3):275-283. PubMed ID: 28832218
[TBL] [Abstract][Full Text] [Related]
10. Severe Asthma in Primary Care: Identification and Management.
Trevor JL; Chipps BE
Am J Med; 2018 May; 131(5):484-491. PubMed ID: 29355509
[TBL] [Abstract][Full Text] [Related]
11. Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
Wright DB; Meurs H; Dekkers BG
Trends Pharmacol Sci; 2014 Nov; 35(11):567-74. PubMed ID: 25441775
[TBL] [Abstract][Full Text] [Related]
12. Complex phenotypes in asthma: current definitions.
Wenzel SE
Pulm Pharmacol Ther; 2013 Dec; 26(6):710-5. PubMed ID: 23880027
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine in asthma: linking phenotypes to targeted treatments.
Chung KF
Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
[TBL] [Abstract][Full Text] [Related]
14. Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
Silkoff PE; Strambu I; Laviolette M; Singh D; FitzGerald JM; Lam S; Kelsen S; Eich A; Ludwig-Sengpiel A; Hupp GC; Backer V; Porsbjerg C; Girodet PO; Berger P; Leigh R; Kline JN; Dransfield M; Calhoun W; Hussaini A; Khatri S; Chanez P; Susulic VS; Barnathan ES; Curran M; Das AM; Brodmerkel C; Baribaud F; Loza MJ
Respir Res; 2015 Nov; 16():142. PubMed ID: 26576744
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for asthma.
Quirce S; Bobolea I; Barranco P
Expert Opin Emerg Drugs; 2012 Jun; 17(2):219-37. PubMed ID: 22607631
[TBL] [Abstract][Full Text] [Related]
16. An orally active geranyl acetophenone attenuates airway remodeling in a murine model of chronic asthma.
Lee YZ; Shaari K; Cheema MS; Tham CL; Sulaiman MR; Israf DA
Eur J Pharmacol; 2017 Feb; 797():53-64. PubMed ID: 28089919
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes and endotypes of uncontrolled severe asthma: new treatments.
Campo P; Rodríguez F; Sánchez-García S; Barranco P; Quirce S; Pérez-Francés C; Gómez-Torrijos E; Cárdenas R; Olaguibel JM; Delgado J; ;
J Investig Allergol Clin Immunol; 2013; 23(2):76-88; quiz 1 p. follow 88. PubMed ID: 23654073
[TBL] [Abstract][Full Text] [Related]
18. Airway Inflammatory Biomarker: Could It Tailor the Right Medications for the Right Asthmatic Patient?
Zedan MM; Osman AM; Laimon WN; Zedan MM; Abo-Elkheir NY; Zaki A
Iran J Immunol; 2016 Jun; 13(2):70-88. PubMed ID: 27350629
[TBL] [Abstract][Full Text] [Related]
19. Xiao-Qing-Long-Tang attenuates allergic airway inflammation and remodeling in repetitive Dermatogoides pteronyssinus challenged chronic asthmatic mice model.
Wang SD; Lin LJ; Chen CL; Lee SC; Lin CC; Wang JY; Kao ST
J Ethnopharmacol; 2012 Jul; 142(2):531-8. PubMed ID: 22658987
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin therapy in asthma.
Dunn RM; Wechsler ME
Clin Pharmacol Ther; 2015 Jan; 97(1):55-65. PubMed ID: 25670383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
